Evotec SE (EVO) Accounts Payables (2009 - 2026)
Evotec SE (EVO) reported Accounts Payables of $64273.9 for Q1 2026, little changed on a YoY basis from $64479.5 in Q1 2025, and down 14.74% sequentially from $75387.0 in Q4 2025.
Evotec SE (EVO) Accounts Payables (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Accounts Payables data on file, last reported at $64273.9 in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables changed 0.32% year-over-year to $64273.9; the trailing twelve-month figure through Mar 2026 stood at $64273.9 (changed 0.32% YoY), and the FY2025 full-year result was $75387.0, down 99.92% from the prior year.
- Accounts Payables slipped to $64273.9 in Q1 2026, from $75387.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $144.5 million in Q4 2023 to a low of -$86317.4 in Q2 2022.
- A 5-year average of $28.0 million and a median of $76073.0 in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 45.62% in 2023 and slumped 99.92% in 2025, its largest moves.
- Tracing EVO's Accounts Payables over 5 years: stood at $99.2 million in 2022, then surged by 45.62% to $144.5 million in 2023, then sank by 36.56% to $91.7 million in 2024, then tumbled by 99.92% to $75387.0 in 2025, then slipped by 14.74% to $64273.9 in 2026.
- Business Quant data shows EVO's Accounts Payables at $64273.9 in Q1 2026, $75387.0 in Q4 2025, and $57850.7 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 64,273.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,273.94 |
| Dec 31, 2025 | 75,386.95 |
| Sep 30, 2025 | 57,850.69 |
| Jun 30, 2025 | 65,635.55 |
| Mar 31, 2025 | 64,479.46 |
| Dec 31, 2024 | 91.68 Mn |
| Sep 30, 2024 | 76,758.95 |
| Dec 31, 2023 | 144.52 Mn |
| Dec 31, 2022 | 99.25 Mn |
| Sep 30, 2022 | 84,659.75 |
| Jun 30, 2022 | -86,317.42 |
| Mar 31, 2022 | 83,882.40 |
| Dec 31, 2021 | 83.05 Mn |
| Sep 30, 2021 | 66,889.18 |
| Dec 31, 2020 | 50.73 Mn |
| Sep 30, 2010 | 6,807.59 |
| Jun 30, 2010 | 7,191.36 |
| Mar 31, 2010 | 7.74 |
| Dec 31, 2009 | 6,494.68 |
| Jun 30, 2009 | 9.76 Mn |